May 10, 2019
Applied DNA to Webcast 2019 Annual Stockholders’ Meeting
STONY BROOK, N.Y.–(BUSINESS WIRE)–Applied DNA Sciences, Inc. (NASDAQ: APDN), will hold its 2019 Annual Meeting of Stockholders on Thursday, May…
Pharmaceuticals, Biotechnology and Life Sciences
STONY BROOK, N.Y.–(BUSINESS WIRE)–Applied DNA Sciences, Inc. (NASDAQ: APDN), will hold its 2019 Annual Meeting of Stockholders on Thursday, May…
– Study results across 17 medicines reflect our commitment to personalized care with advances in targeted therapies, immunotherapy, and diagnostics,…
GAITHERSBURG, Md.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/CRO?src=hash" target="_blank"gt;#CROlt;/agt;–Smithers Avanza, a contract research organization (CRO) specializing in supporting development of large molecule therapeutics, announced…
CHICAGO & CAMBRIDGE, Mass.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/DigitalDrugDesign?src=hash" target="_blank"gt;#DigitalDrugDesignlt;/agt;–Exicure, Inc. (OTCQB: XCUR), the pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical…
Company Reports $1.7 Million in Net Product Revenues from COPIKTRA™; Issues Product Revenue Guidance for 2019 Cash, Cash Equivalents and…
Conference call begins today at 4:30 p.m. Eastern time EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company…
— Initiated Screening of Participants to Enroll in the PHYOX™2 Phase 2 Pivotal Trial of DCR-PHXC for the Treatment of…
– Top-line Data from INVICTUS Pivotal Phase 3 Clinical Study of Ripretinib in Fourth-line and Fourth-line Plus GIST Patients Expected…
Positive OpRegen® Data Presented at Association for Research in Vision and Ophthalmology Annual Meeting Announced Issuance of New Patent for…
– Conference Call Today at 4:30 p.m. ET – SEATTLE–(BUSINESS WIRE)–Omeros Corporation (NASDAQ: OMER), a commercial-stage biopharmaceutical company committed to…